In what health authorities are calling a game-changer, the United Kingdom has approved a long-acting HIV prevention injection to be administered every two months as an alternative to daily oral ...
Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat the disease's ongoing spread throughout the country. Over 100,000 people ...
England’s drug pricing regulator recommended GSK Plc’s HIV prevention injection, making it the first long-acting pre-exposure treatment for use within the National Health Service. The shot, known as ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new long-lasting prophylactic treatment for HIV-1 that is administered once every 6 months. Lenacapavir (Yeytuo, Gilead ...
The Federal Government has announced plans to roll out a new long-acting HIV prevention injection, Lenacapavir, as part of efforts to accelerate progress toward ending HIV/AIDS as a public health ...
– Approval Based on Phase 3 PURPOSE 1 and PURPOSE 2 Data that Showed ≥99.9% of Participants Remained HIV Negative on Twice-Yearly Injectable Yeztugo – – Yeztugo, Nearly 20 Years in the Making, ...